Tamarly Intelligence
Company · TEVA (New York Stock Exchange)

Teva Pharmaceutical Industries Ltd

Pharmaceutical Preparations

Key figures
Revenue, 2025
$17.26B
Employees
42,535
Industry
Pharmaceutical Preparations (SIC 2834)
Institutional holders
673 at 30 Jun 2026 (653 the quarter before)
SEC number
818686
LEI
549300BAFGM4RC74ZJ94

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026

About

Teva Pharmaceutical Industries Ltd is an Israeli pharmaceutical company in pharmaceutical industry, headquartered in Tel Aviv, founded in 1901.

Source: Wikidata

Latest filings
16 Sept 2026
8-K 8-K
14 Sept 2026
8-K 8-K
11 Sept 2026
8-K 8-K
3 Sept 2026
8-K 8-K
3 Sept 2026
8-K 8-K

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.